Year archive

CLINUVEL PHARMACEUTICALS LIMITED — 2015 filings

All 36 regulatory filings released by CLINUVEL PHARMACEUTICALS LIMITED (CUV) in 2015, sourced directly from the official regulator.

36 Filings

2015 Period

2015 filings (36)

Filing	Released	Lang
Positive preliminary results in Singaporean vitiligo study 3 pages 137.5KB Regulatory Filings	2015-12-02	English
Update on North American vitiligo program for SCENESSE 3 pages 133.1KB Regulatory Filings	2015-12-02	English
Chairman's Address to Shareholders 2 pages 106.5KB AGM Information	2015-11-23	English
CEO's AGM Presentation 39 pages 3.1MB AGM Information	2015-11-23	English
Results of Meeting 3 pages 101.5KB Declaration of Voting Results & Voting Rights Announcements	2015-11-23	English
Change in substantial holding 5 pages 3.5MB Regulatory Filings	2015-11-03	English
Appendix 4C - quarterly 5 pages 123.7KB Interim / Quarterly Report	2015-10-29	English
Notice of Annual General Meeting/Proxy Form 14 pages 664.4KB AGM Information	2015-10-22	English
Annual Report to shareholders 53 pages 3.5MB Regulatory Filings	2015-10-22	English
Appendix 4G and Corporate Governance Statement 19 pages 585.7KB Governance Information	2015-10-22	English
Change in substantial holding 6 pages 575.5KB Regulatory Filings	2015-10-06	English
AGM Date 1 page 257.3KB AGM Information	2015-10-05	English
FDA Meeting 2 pages 271.4KB Regulatory Filings	2015-10-04	English
Becoming a substantial holder 10 pages 793.4KB Regulatory Filings	2015-09-22	English
SCENESSE released for European Distribution 3 pages 286.5KB Regulatory Filings	2015-09-20	English
Preliminary Final Report 48 pages 907.6KB Annual Report	2015-08-30	English
FDA grants Clinuvel a Type C Meeting 3 pages 144.1KB Regulatory Filings	2015-08-26	English
Appendix 4C - quarterly 5 pages 123.9KB Interim / Quarterly Report	2015-07-30	English
Ceasing to be a substantial holder 5 pages 163.5KB Major Shareholding Notification	2015-07-29	English
Clinuvel Newsletter - July 2015 3 pages 176.5KB Management Reports	2015-07-14	English
NEJM publishes Phase III SCENESSE studies 3 pages 134.9KB Regulatory Filings	2015-07-01	English
SCENESSE Commercialisation Update 2 pages 283.5KB Regulatory Filings	2015-06-04	English
Clinuvel announces innovative melanocortin 3 pages 131.7KB Capital/Financing Update	2015-05-04	English
Appendix 4C - quarterly 5 pages 123.3KB Interim / Quarterly Report	2015-04-26	English
Clinuvel Relocates Melbourne Office 1 page 208.2KB Regulatory Filings	2015-03-30	English
SCENESSE breakthrough featured in peer-reviewed editorial 1 Regulatory Filings	2015-03-19	English
SCENESSE data presented at US dermatology conference 2 pages 119.4KB Regulatory Filings	2015-03-19	English
Appendix 3B 12 pages 523.6KB Capital/Financing Update	2015-03-19	English
Clinuvel Newsletter - March 2015 4 pages 1.1MB Management Reports	2015-03-11	English
Appendix 3B 12 pages 526.1KB Share Issue/Capital Change	2015-03-01	English
Half Yearly Report and Accounts 12 pages 273.9KB Interim / Quarterly Report	2015-02-24	English
Appendix 4C - quarterly 5 pages 124.0KB Interim / Quarterly Report	2015-01-29	English
Appendix 3B 12 pages 525.7KB Share Issue/Capital Change	2015-01-22	English
Change of Director's Interest Notice 8 pages 661.2KB Director's Dealing	2015-01-22	English
Clinuvel appoints new Non-Executive Director 1 page Board/Management Information	2015-01-20	English
Initial Director's Interest Notice 2 pages 342.2KB Director's Dealing	2015-01-20	English

Filings by year

2026 21 filings
2025 67 filings
2024 96 filings
2023 62 filings
2022 63 filings
2021 59 filings
2020 69 filings
2019 72 filings
2018 54 filings
2017 32 filings
2016 52 filings
2015 36 filings
2014 59 filings
2013 39 filings
2012 38 filings
2011 47 filings
2010 56 filings
2009 45 filings
2008 43 filings
2007 54 filings
2006 10 filings
2005 74 filings
2004 49 filings
2003 53 filings
2002 2 filings